Cite
Derakhshani A, Hashemzadeh S, Asadzadeh Z, et al. Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine. Cancers (Basel). 2021;13(10)doi: 10.3390/cancers13102414.
Derakhshani, A., Hashemzadeh, S., Asadzadeh, Z., Shadbad, M. A., Rasibonab, F., Safarpour, H., Jafarlou, V., Solimando, A. G., Racanelli, V., Singh, P. K., Najafi, S., Javadrashid, D., Brunetti, O., Silvestris, N., & Baradaran, B. (2021). Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine. Cancers, 13(10), . https://doi.org/10.3390/cancers13102414
Derakhshani, Afshin, et al. "Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine." Cancers vol. 13,10 (2021). doi: https://doi.org/10.3390/cancers13102414
Derakhshani A, Hashemzadeh S, Asadzadeh Z, Shadbad MA, Rasibonab F, Safarpour H, Jafarlou V, Solimando AG, Racanelli V, Singh PK, Najafi S, Javadrashid D, Brunetti O, Silvestris N, Baradaran B. Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine. Cancers (Basel). 2021 May 17;13(10). doi: 10.3390/cancers13102414. PMID: 34067631; PMCID: PMC8155910.
Copy
Download .nbib